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ABSTRACT Various tissues and cells in culture contain
a specific inhibitor of DNase I (EC 3.1.4.5). In this paper
evidence is presented that this inhibitor is actin, one of
the major structural proteins of muscle and nonmuscle
cells. (a) The inhibitor is a major cellular component con-
stituting 5-10% of the soluble protein. (b) It migrates with
actin on sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, having a characteristic molecular weight
of 42,000. (c) It has an amino-acid composition closely
similar to that of actin. (d) The peptide maps of the two
proteins are nearly identical. (e) Skeletal muscle actin in-
hibits the enzymatic activity of DNase J. (f) DNase I-aga-
rose affinity chromatography quantitatively retains puri-
fied skeletal muscle actin, and actin, specifically, from
high-speed supernatants of whole cell extracts. (g) An
antibody to purified inhibitor protein from calf thymus,
used in indirect immunofluorescence on cells grown in
culture, stains a two-dimensional network of fibers similar
to that seen with an actin-specific antibody.
The observation that actin can be isolated by DNase-
agarose affinity chromatography provides a useful tool for
the biochemical study of actin under different physi-
ological conditions.
Various eukaryotic cells contain a protein that strongly and
specifically inhibits the activity of DNase I (EC 3.1.4.5) (1-6).
The inhibitor from calf spleen has been purified to homo-
geneity (7, 8). The protein, which under certain conditions
readily forms high-molecular-weight aggregates, acts in the
monomeric form by binding tenaciously to the enzyme. This
interaction gives rise to a complex containing one molecule
each of DNase I and inhibitor (9). Analogous proteins from
calf thymus (10) and rat, serum (11) have also been extensively
purified and shown to have properties similar to those of the
spleen inhibitor. The inhibitor is present in remarkably large
amounts in the cell, comprising 5-10% of the soluble protein
of the crude extract (10, 12). Its physiological significance,
however, has remained unknown.
DNase I was isolated and crystallized from bovine pancreas
by Kunitz in 1948 (13). Recently this enzyme has been sub-
jected to an extensive investigation (14-21), including the
determination of its amino acid sequence (22). So far the only
known enzymatic activity found associated with DNase I is
its ability to degrade DNA, and the DNase inhibitor has been
primarily thought of as a protein controlling or modifying this
activity.
Actin is a major structural component of all cell types (23).
It has been implied to be involved in a large number of cellular
Abbreviations: DNase I, deoxyribonucleate 5'-oligonucleotido-
hydrolase; EC 3.1.4.5 (pancreatic deoxyribonuclease); NaDod-
S04, sodium dodecyl sulfate.
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functions like cytokinesis, membrane ruffling, cell locomotion,
attachment, of cells to a substratum, pinocytosis, and main-
tenance of cell shape (24-30). Thus, actin and actin-containing
structures appear to have a broad spectrum of activities within
a cell, a number of which may still be unknown. Recently an
antibody was obtained against mouse fibroblast actin. When
this antibody was used in indirect immunofluorescence on
cells grown in culture, it revealed a complex network of actin-
containing fibers (31). These fibers were subsequently shown
to be identical to submembraneous bundles of microfilaments
(32).
This paper presents biochemical and immunological evi-
dence that actin and the widely occurring DNase I inhibitor
are identical proteins. The implications of this observation
for the cellular function of actin and DNase I are discussed.
MATERIALS AND METHODS
DNase I (1 X.crystallized; Schwartz/Mann) was used without
further purification for DNase and DNase inhibitor assays
and for the preparation of DNase-agarose (see below). DNase
I inhibitor from calf thymus was purified as described by
Lindberg and Skoog (10). In the experiments reported here,
the second inhibitor peak from the DEAE-cellulose chroma-
tography was used. DNase and inhibitor assays were per-
formed as described (5); one inhibitor unit is defined as the
amount of inhibitor that causes a 1% inhibition of the activity
of 1 ,4g of DNase I.
Purified chicken skeletal muscle actin was a generous gift
from Dr. Susan Lowey.
Affinity Chromatography on DNase-Agarose. DNase-
agarose was prepared by the CNBr activation method (33),
essentially according to the procedure described by Kato and
Anfinsen (34). For this purpose, 25 g of Biogel A15 (BioRad)
was washed with distilled water on a Bfichner funnel and
resuspended in'60 ml of water. Cyanogen bromide (4.5 g) was
dissolved in 135 ml of water and added to the suspended
agarose beads. The mixture was stirred with dropwise addition
of 2 M NaOH to keep the pH at 11.0-11.5. After completion
of the reaction (20 min), the resin was washed on a Bfichner
funnel with 0.1 M NaHCO3 and resuspended in 25 ml of 0.1 M
NaHCO3, 0.1 mid CaCl2. DNase I, 20 mg dissolved in 2 ml of
0.1 M NaHCO3, 0.1 mM CaCl2, was mixed with the activated
agarose and stirred overnight. The whole procedure was
carried out at 0-4'. The product DNase-agarose was washed
free of unbound protein and used for purification of DNase I
inhibitor as described by Lindberg and Eriksson (12), except
for minor changes in the composition of the elution buffers as
indicated in the figure legends. The peak fractions from the
affinity chromatography (see Figs. 2 and 3) were pooled as
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FIG.. 1. Inhibition of D)Nase I by actin from chicken skeletal
muscle. Purified act~in from chicken skeletal muscle was 1yoph-
ilized from a solution containing 10 mM Tris-HCI (pH 7.4),
0.1 m.AI CaC12, 0.1Im-NI ATP, 1 mAI dit~hiothreitol. A stock solu-
tion was prepared by dissolving the protein in 50 mM Tris-HCI
(pH 7.4), 1 mAl CaCl1 at a concentration of I mg/ml. The D)Nase
assay was performed as described (5s). In the above experiment,
increasing amounts of actin were added to the standard amount
of D)Nase (0.2 ,ug) immediately before the addition of the sub-
strate. In the diagram, the results are expressed as percent re-
maining activity of the D)Nase against, the amount, of actin added
per ,ug of enzyme. *, Native actin; O. act-in treated for 2 min at
Coo
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inc 1ate anhbdialyzed against distilled waterfo n 18 hr. The
samples were lyophilized and redissolved in electrophoresis
sample buffer [50ml Trisc HaCn (pH 6.8), 2%r sodium dodec)l
sulfate (NaDodS04),' 10% glycerol, 0.002%o hromphenol
blue, 0.1Ma dithiothreitol ] and analyzed by NaDodSo4-
polyaerylamide slab-gel electrophoresis. Elect~rophoresis was
terformen according to the Tris-glyeinie system of Laemmli
(35) as described by Anderson et al. (36). The gels contained
12.5% acrylamidle and 0.067%o bisaerylamide.
Tryptic peptide analysis was( performed essentially as
lescribed by Leggett-Bailey (37) and Anderson et al. (36).
Antibody Preparation. Antibodies against the DNase I
inhibitor from calf thymus were obtained by immunization of
rabbits by a procedure similar to that previously used by
Lazarides and Weber for preparation of actin antibodies (31).
The immunization was kindly performed for use by Dr. F.
'M'ller at the State University of N~ew York at Stonybrook.
The thymus inhibitor was purified as described (10). This
preparation was about 95%^ pure (see Fig. 3C). The protein
was freed from salt by dialysis against water and lyophilized.
It was then dissolved in electrophoresis sample buffer (see
above) at a concentration of 1-2 mg/ml by heaing for 4midl
in boiling water. For immunization, 0.5 mg of the denatured
and reduced inhibitor protein was thoroughly mixed with
complete Fruend's adjuvant and injected subcutaneously in
rabbits. Three weeks later, the rabbits were injec'ted intra-
venously with 0.1 ml of the denatured protein, and this step
was repeated every third dat . After a month of immunization
the rabbits were bled and the serum was collected. The gamma
globulinscere partially purified by precipitation with50%a
ammonium sulfate. After dialysis against 0.15 AI NaCl, 10
ATrisb HC (pH 7.8), the antibod preparation was stored
at -20or. Indirect immunofluoresoence of cells grown on
coverslips was performed as described for the actin-specific
antibody (31).
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FIG. 2. Affinity chromatography of actin from chicken skeletal
muscle on I)Nase-agarose. A stock solution of purified actin was
prepared as described in the legend to Fig. 1. The protein (0.5
mg) was diluted with an equal volume of 0.5 A/I sodium acetate,
1 mMI CaCl2, 30% glycerol (buffer A), and applied to a DNase-
agarose column (1.2 ml containing 1 mg of DNase) packed in a
a-ml plastic disposable syringe. (A) The protein was eluted step-
wise from the affinity column with 6 ml each of the following
buffers (1-ml fractions were collected): (1) buffer A, (2) buffer A
plus 0.75 MI guanidine-HCl (pH 6.15), (3) buffer A plus 3.0 M
guanidine HCl (pH 6.5). The peak fractions were pooled and
processed for NaDodSO4-polyacrylamide slab gel electrophoresis
as described in Mfaterials and Methods. (B) The lyophilized frac-
tions (1-3) were dissolved in equal volumes of NaDodSO4
sample buffer; and 10 ,ul of fractions 1 and 2 and 5 ,1A of fraction
3 were applied to the gel.
RESULTS
The DNase I inhibitor is a major soluble protein component
in eukaryotic cells with a molecular weight in the range of
42,000 (10). This observation led to the idea of looking for a
possible resemblance between this protein and actin, which
also is a major cellular protein and characteristically migrates
on NaDodSO4-polyacrylamide gel electrophoresis with a
molecular weight of 42,000. An indication that these two
proteins could be related was obtained in the comparison of
the amino-acid composition of the inhibitor from calf spleen
(7) and actin from different sources, as reported (38-41). We
recalculated the amino-acid residues, using the molecular
weight of 41,785 calculated from the amino-acid sequence data
reported for rabbit skeletal muscle actin (38). In the amino-
acid composition of the inhibitor, 10 of the 18 listed amino
acids did not deviate by more than i 1 residue and three by
+2 residues from the corresponding values of rabbit skeletal
muscle actin. Most likely, this is within experimental error.
Of the remaining five amino acids that showed slightly larger
deviations, four constitute a group that, in general, show
variations among actins from different species.
The close similarlity of the amino-acid composition of actin
and the inhibitor prompted us to test the effect of purified
actin on the enzymatic activity of DNase I. As shown in Fig.
1, purified actin. from chicken skeletal muscle effectively
inhibits the degradation of DNA by the enzyme. The kinetics
of the inhibition implies that around 3 lug of actin are needed to
inhibit 1 /ug of DNase I. Assuming that actin causes this
inhibition in the same mamner as the calf spleen and thymus
Proc. Nat. Acad. Sci. USA 71 (1974)
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FIG. 3. Fractionation of a KB cell high-speed supernatant by affinity chromatography on DNase-agarose. KB cells grown in spinner
culture (3 X 105 cells per ml) were labeled with [35S]methionine (specific activity 100 Ci/mmole) at 2 ,4Ci/ml. After 9 hr of labeling, a
crude extract was prepared from the collected cells by homogenizing in 50 mM Tris HCl (pH 7.5), 1 mM CaCl2. A high-speed supernatant
was obtained boy centrifugation of the crude extract for 2 hr at 50,000 rpm (+40) in a Spinco SW50.1 rotor. The DNase I inhibitory ac-
tivity of the supernatant was 8000 units/ml (for definition see Materials and Methods). For affinity chromatography (panel A), 16 A28o
units of the supernatant were applied to a column of DNase-agarose containing 1.7 mg of enzyme. Stepwise elution with 25 ml of each
buffer (2.5-ml fractions) was performed as follows: (1) 0.15 M NaCl, 50 mM Tris HCl (pH 7.4), 1 mM CaCl2; (2 and 3) buffer A (see
legend to Fig. 2); (4) buffer A plus 0.75 M guanidine HCl; and (5) buffer A plus 3 M guanidine HCl. The fractions were pooled as indi-
cated in panel A and processed for NaDodSO4-polyacrylamide slab-gel electrophoresis as described in Materials and Methods. The ly-
ophilized samples were dissolved in equal volumes of NaDodSO4 sample buffer, and 10 1.d of each of the samples was loaded on the gel,
except for sample 1 where 5,u1 was used. The results of the electrophoresis are presented in panel B. TM refers to KB cell tropomyosin
(unpublished observation). Panel C shows the coelectrophoresis of (a) DNase I inhibitor purified from calf thymus, (b) the protein from
KB cells purified by affinity chromatography on DNase agarose, and (c) actin from chicken skeletal muscle.
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FIG. 4. Tryptic peptide map analysis of actin and DNase I
inhibitor. For peptide mapping, protein samples (100-200 Mug)
were oxidized and digested with trypsin as described (36, 37).
Panel A shows the analysis of a mixture of the tryptic peptides of
actin from chicken skeletal muscle and the [35S] methionine-
labeled protein from KB cells purified on DNase-agarose (see
Fig. 3A and B). Panel B shows the corresponding analysis of the
DNase inhibitor from calf thymus. The peptides of skeletal
muscle actin and the thymus inhibitor were stained with nin-
hydrin. The plate with the peptides of skeletal muscle actin was
autoradiographed to reveal the [35S]methionine-containing pep-
tides of the KB cell protein (indicated by dotted lines).
inhibitors (formation of a 1:1 addition complex) (9, 10), then
at least 50% of the actin molecules in this preparation was
available for interaction with DNase. A 5-fold excess of actin
inhibited the enzyme more than 99%.
Affinity chromatography on DNase-agarose columns was
used to study further the interaction between purified skeletal
muscle actin and DNase I. This method was successfully used
previously to purify the DNase inhibitor from crude extracts
of calf thymus (12). Only one major protein was shown to bind
tenaciously to the DNase-agarose. It could be eluted with a
buffer containing 3 M guanidine HCl and was shown to be
identical to the previously purified thymus inhibitor. In the
experiments illustrated in Fig. 2, 0.5 mg of purified skeletal
muscle actin was applied to a column containing approxi-
mately 1 mg of DNase I. The column was washed and eluted
with the different salt solutions, and the peak fractions were
pooled and processed for slab gel electrophoresis. The results
(Fig. 2A and B) demonstrated that virtually all actin was
retained by the DNase-agarose and eluted with 3 M guani-
dine * HCl. The material passing through the column un-
adsorbed and having a high A26o/A28o ratio was due to excess
ATP present in the actin preparation.
The specificity and applicability of the affinity chromatog-
raphy in the purification of the DNase I inhibitor (= actin)
is further illustrated by the experiment shown in Fig. 3.
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FIG. 5. Indirect immunofluorescence with actin and DNase inhibitor antibodies. Human skin fibroblasts (designated CRL 1139, EN
SON, cystic fibrosis) were obtained from the American Tissue Culture Collection. The cells were grown in Dulbecco's modification of
Eagle's medium containing 10% fetal calf serum, 1 mg/ml of gentamycin, 100 units/ml of penicillin, and 100 jug/ml of streptomycin.
The actin-specific antibody was obtained as described (31). The antibody to purified thymus inhibitor was prepared as described in
Materials and Methods. Photographs show immunofluorescent staining of human cells with the actin-specific antibody (panel a) and with
antibody to the DNase inhibitor (panel b).
Here, a high-speed supernatant of an extract from [35S]_
methionine-labeled KB cells was passed through a column
of DNase-agarose- (Fig. 3A). The eluted fractions were pooled
and processed as in the previous experiment. As shown by
NaDodSOc-gel electrophoresis (Fig. 3B), one major protein,
which electrophoresed with actin, was quantitatively and
specifically retained by the column and eluted with 3 M
guanidine - HCl. It has previously been shown that when such
high-speed supernatants of cultured cells are analyzed by
NaDodSO4 gel electrophoresis, the major band, which mi-
grates with a molecular weight of 42,000, is actin (31).
Twenty-five percent of the methionine label of the high-speed
supernatant was recovered in the 3 M guanidine-HCl frac-
tion; 95% of this radioactivity migrated with the actin band
(data not shown). Fig. 3C shows the coelectrophoresis of
chicken skeletal muscle actin, DNase I inhibitor from calf
thymus, and actin from KB cells purified by affinity chroma-
tography on DNase-agarose. All three proteins migrated
identically. The nature of the minor components contaminat-
ing the actin eluted from the DNase-agarose is not known,
but it is possible that they have some relationship to the actin-
DNase I system.
To further substantiate the identification between the
DNase I inhibitor and actin, we compared samples of the two
proteins by tryptic peptide analysis. The DNase I inhibitor
and actin used in this analysis had both been purified by
conventional purification methods. As illustrated in Fig. 4A
and B, the distribution of peptides in the two maps was
closely similar. Furthermore, when the [33S]methionine-
labeled protein from KB cells purified by affinity chromatog-
raphy on DNase-agarose (Fig. 3B) was subjected to peptide
map analysis (Fig. 4A), four of the [35S]methionine-contain-
ing peptides were well resolved and coincided with ninhydrin-
stained spots from chicken skeletal muscle actin.
Actin purified by NaDodSO4-polyacrylamide gel electro-
phoresis hag been shown to be antigenic in rabbits and to give
rise to an antibody, which in indirect immunofluorescence
reveals actin-containing filaments in cells (31). A similar
Proc. Nat. Acad. Sci. USA 71 (1974)
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method was used here to obtain an antibody against DNase I
inhibitor. For this purpose, the inhibitor purified from calf
thymus by conventional techniques was denatured with SDS
and reduced with dithiothreitol and used for immunization in
rabbits as described in Materials and Methods. The resulting
antibody was tested on human skin fibroblasts by indirect
immunofluorescence. These cells were chosen because they are
large and well spread and contain a highly developed actin
fiber network. Fig. 5a shows a cell stained with the actin
antibody, and Fig. 5b a cell stained with the DNase inhibitor
antibody. In both cases an array of fibers was revealed. The
fibers mark the cell periphery, often converge to focal
points, and are frequently seen to span the entire cell length.
As judged by immunofluorescence, both antibody prepara-
tions show crossreactivity with actin-containing fibers in a
variety of cell types.
DISCUSSION
The biochemical and immunological evidence presented above
proves that actin is the widely occurring inhibitor of DNase
I. The interaction between actin and the enzyme results in the
formation of a stable complex. As shown earlier (7, 12) and
corroborated in this work (Fig. 3), this association is char-
acterized by a high degree of specificity.
DNase I has so far been thought of as a DNA degrading
enzyme. The interaction of actin with DNase I may mean that
actin controls the nucleolytic activity of this enzyme during
the cell cycle. It is also possible that the complex has a specific
function in DNA metabolism. A third alternative is that the
primary function of DNase I is not related to DNA but to the
formation and function of actin filaments. However, these
possibilities are difficult to evaluate, since little information
is available at present on the occurrence of DNase I type
enzymes in nonpancreatic cells and on the existence of DNase
I-actin complexes in vivo.
The specificity of the interaction of actin and DNase I
makes the isolation of actin by affinity chromatography of
considerable experimental value. Actin isolated by this method
from high-speed supernatants of cellular extracts is both
radiochemically and by staining more than 90% pure. Thus,
this method can be conveniently applied to study actin
modifications occurring throughout the cell cycle or under
various physiological conditions.
Finally, it should be pointed out that the DNase inhibitory
activity of actin provides a novel assay for this structural
protein. The high specificity of this interaction makes it
possible to determine the presence of actin in crude extracts of
any type of cell.
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